InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Gentile Kimberly, 首席运营官. Director active across 2 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 6 reports have been logged. History available since 25 November 2021. The latest transaction was disclosed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Gentile Kimberly is Director of Clinical Operations and SVP, Clinical Operations at Biohaven Ltd. and Biohaven Pharmaceutical Holding Co Ltd. She has 6 filings in total, and across the 6 recent filings observed between 2021-11-26 and 2026-01-07, sales total EUR 1760027, with the most frequent transaction nature listed as Option exercise.